Children's Pharmaceutical Market will reach 66.9 billion in 2015
Release time: 2011-05-24 & nbsp & nbsp & nbsp Source:
Business Club, May 20. There are only 60 children in children in my country。
Pharmaceuticals that need to be suitable for their physiological characteristics can help them get rid of the pain of illness。Statistics data show，my country has 367 million children，This means that the actual capacity of the Chinese children's drug market is huge。Only take a cold and fever as an example，The average annual incidence of children in the age of 0-12 is 3.72 times，Calculated according to 5 days a day per disease，If you take 3 packs of cold particles per day，A total of 20.48 billion packs are needed。According to preliminary predictions of relevant agencies，Chinese Children's Medicine has at least 50 billion yuan in market space。
But，Few of children's medicines in thousands My stake betting appMy stake betting appof domestic pharmaceutical factories，and have strong scientific research strength，Professional pharmaceutical factories that can develop new children's new drugs are even more rare。90%of the market share is divided by a large number of foreign companies。What's more worrying is，90%of the drugs in the domestic market have no children's dosage，Pediatrician depends on experience medicine，Great safety hazards。Not only the pharmaceutical market，In the field of health products，Foreign capital、The joint venture also performs very strong。In the children's vitamin market，More than 90%of the share is Wyeth、Roche、Shi Guibao's major companies occupy。
March last year，Kangzhi Pharmaceutical wrote in its "Prospectus": "On the one hand, children's medicine requirements are particularly high in safety; on the other hand,，Children's medication market should have been a big market，But the current adult drugs are crowded in the market for children's medication，If there is no special sales channel，Usually pharmaceutical manufacturers cannot achieve good benefits in this market。”
According to the director of the China Children's Healthcare Disease Prevention and Guidance Center、Dai Yaohua, director of the World Health Organization (WHO) Child Health Cooperation Center, told reporters: "The current status of Chinese children's drugs needs to be changed as soon as possible，Government、Enterprise、The public should work together to make a medicine for children。”
According to her introduction，Among more than 3,000 stake sports betting appMy stake betting appdrugs，Children's drugs are roughly 60 kinds，But even these 60 drugs，There is also a single dosage type、Questions for monotonous varieties。
At the same time，It is worth noting is，Monitoring indicates，Adverse reaction rate of Chinese children's drugs is two times the adult，Newborns are as high as 4 times，One -third of Chinese dying every year in China is children。The core reason is that children are "available"，Children have to reduce adult medication，Children's drug metabolism is different from adults，Its liver、Kidney is under development，It is easy to cause adverse drug reactions。
Individual companies drink "head soup".
The reporter learned from the interview and investigation，Some domestic Chinese medicine companies in China are developing the children's medicine market，Introduction of products that are suitable for children's use。From the situation of the relevant listed companies in the first quarter of this year，Channel in the children's pharmaceutical market、Enterprises with advantages in word of mouth have drank "head soup"。
Shanda Huatt Holding subsidiary Dain Pharmaceutical's contribution to the company in the first quarter of this year。Company 1 quarterly display，Dain Pharmaceutical, which produces children's calcium supplement products, is 15 million yuan，and only 4 million yuan in the same period last year。
According to Shanghai Securities Medical Researcher Zhao Bing, Introduction，From the product structure of the company，Yi Kexin accounts for more than 75%of its sales revenue，Stake Sports BettingOther second -tier products stake betting appand Gai Di Xin、Right Forraphyhydride iron oral solution, etc.。Yikexin is vitamin AD drops，This drug is children's health medicine，Although there are more similar products on the market，But the company's market share has always maintained the first。
According to CITIC Securities Industry Researcher，The company's product positioning is clear，firmly seize the fastest market segment of pediatrics,。At the same time，Because the company's product quality is reliable、Low -quality beauty，and the marketing model that drives the pharmacy sales of pharmacies to make the product establish a good reputation among parents，Save a lot of promotion expenses for the company。
The company's director Fan Zhisheng told reporters，The positioning of Dain creatures is clear，It will become a leading company in the field of children's health and treatment。In the future, the company will consolidate channels and word of mouth，and further bigger the original superior product。
Even so，Du wood is difficult to become forest。Although there are already such as Kangzhi Pharmaceutical、Shanda Huatt and other companies began to deeply cultivate the children's pharmaceutical market，But the development of the entire market still requires the investment of more enterprises。
Another，In terms of government support，Relevant experts call for，my country should learn from foreign experience，Actively support children's medication production enterprises。"Including a certain market protection period for giving pharmaceutical Stake Sports Bettingcompanies to develop children'Stake Sports Bettings drugs，Promoting clinical research of pharmaceutical companies to actively conduct children's drugs。Encourage children's pharmaceutical manufacturers through union、Merge、Reorganization，Realize resource gathering、Asset value -added，Forms a strong competitiveness。Another，The state can also adopt loans and rewards to give children drug research to support，This not only increases the enthusiasm of children's drug research，To a certain extent, it relieves the difficulty of less capital，Two -one in -one。"an expert suggestion to say。(Royal)
Pharmaceuticals that need to be suitable for their physiological characteristics can help them get rid of the pain of illness。Statistics data show，my country has 367 million children，This means that the actual capacity of the Chinese children's drug market is huge。Only take a cold and fever as an example，The average annual incidence of children in the age of 0-12 is 3.72 times，Calculated according to 5 days a day per disease，If you take 3 packs of cold particles per day，A total of 20.48 billion packs are needed。According to preliminary predictions of relevant agencies，Chinese Children's Medicine has at least 50 billion yuan in market space。
But，Few of children's medicines in thousands My stake betting appMy stake betting appof domestic pharmaceutical factories，and have strong scientific research strength，Professional pharmaceutical factories that can develop new children's new drugs are even more rare。90%of the market share is divided by a large number of foreign companies。What's more worrying is，90%of the drugs in the domestic market have no children's dosage，Pediatrician depends on experience medicine，Great safety hazards。Not only the pharmaceutical market，In the field of health products，Foreign capital、The joint venture also performs very strong。In the children's vitamin market，More than 90%of the share is Wyeth、Roche、Shi Guibao's major companies occupy。
March last year，Kangzhi Pharmaceutical wrote in its "Prospectus": "On the one hand, children's medicine requirements are particularly high in safety; on the other hand,，Children's medication market should have been a big market，But the current adult drugs are crowded in the market for children's medication，If there is no special sales channel，Usually pharmaceutical manufacturers cannot achieve good benefits in this market。”
According to the director of the China Children's Healthcare Disease Prevention and Guidance Center、Dai Yaohua, director of the World Health Organization (WHO) Child Health Cooperation Center, told reporters: "The current status of Chinese children's drugs needs to be changed as soon as possible，Government、Enterprise、The public should work together to make a medicine for children。”
According to her introduction，Among more than 3,000 stake sports betting appMy stake betting appdrugs，Children's drugs are roughly 60 kinds，But even these 60 drugs，There is also a single dosage type、Questions for monotonous varieties。
At the same time，It is worth noting is，Monitoring indicates，Adverse reaction rate of Chinese children's drugs is two times the adult，Newborns are as high as 4 times，One -third of Chinese dying every year in China is children。The core reason is that children are "available"，Children have to reduce adult medication，Children's drug metabolism is different from adults，Its liver、Kidney is under development，It is easy to cause adverse drug reactions。
Individual companies drink "head soup".
The reporter learned from the interview and investigation，Some domestic Chinese medicine companies in China are developing the children's medicine market，Introduction of products that are suitable for children's use。From the situation of the relevant listed companies in the first quarter of this year，Channel in the children's pharmaceutical market、Enterprises with advantages in word of mouth have drank "head soup"。
Shanda Huatt Holding subsidiary Dain Pharmaceutical's contribution to the company in the first quarter of this year。Company 1 quarterly display，Dain Pharmaceutical, which produces children's calcium supplement products, is 15 million yuan，and only 4 million yuan in the same period last year。
According to Shanghai Securities Medical Researcher Zhao Bing, Introduction，From the product structure of the company，Yi Kexin accounts for more than 75%of its sales revenue，Stake Sports BettingOther second -tier products stake betting appand Gai Di Xin、Right Forraphyhydride iron oral solution, etc.。Yikexin is vitamin AD drops，This drug is children's health medicine，Although there are more similar products on the market，But the company's market share has always maintained the first。
According to CITIC Securities Industry Researcher，The company's product positioning is clear，firmly seize the fastest market segment of pediatrics,。At the same time，Because the company's product quality is reliable、Low -quality beauty，and the marketing model that drives the pharmacy sales of pharmacies to make the product establish a good reputation among parents，Save a lot of promotion expenses for the company。
The company's director Fan Zhisheng told reporters，The positioning of Dain creatures is clear，It will become a leading company in the field of children's health and treatment。In the future, the company will consolidate channels and word of mouth，and further bigger the original superior product。
Even so，Du wood is difficult to become forest。Although there are already such as Kangzhi Pharmaceutical、Shanda Huatt and other companies began to deeply cultivate the children's pharmaceutical market，But the development of the entire market still requires the investment of more enterprises。
Another，In terms of government support，Relevant experts call for，my country should learn from foreign experience，Actively support children's medication production enterprises。"Including a certain market protection period for giving pharmaceutical Stake Sports Bettingcompanies to develop children'Stake Sports Bettings drugs，Promoting clinical research of pharmaceutical companies to actively conduct children's drugs。Encourage children's pharmaceutical manufacturers through union、Merge、Reorganization，Realize resource gathering、Asset value -added，Forms a strong competitiveness。Another，The state can also adopt loans and rewards to give children drug research to support，This not only increases the enthusiasm of children's drug research，To a certain extent, it relieves the difficulty of less capital，Two -one in -one。"an expert suggestion to say。(Royal)
